HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Junichi Shimizu Selected Research

Junichi Shimizu Research Topics

Disease

32Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 11/2005
16Neoplasms (Cancer)
11/2023 - 11/2005
8Lung Neoplasms (Lung Cancer)
09/2023 - 06/2008
7Neoplasm Metastasis (Metastasis)
04/2021 - 08/2005
6Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2022 - 10/2008
5Adenocarcinoma of Lung
03/2021 - 10/2008
4Adenocarcinoma
01/2017 - 10/2008
3Pneumonia (Pneumonitis)
01/2022 - 11/2018
3Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 11/2005
2Disease Progression
11/2017 - 01/2007
2Hepatocellular Carcinoma (Hepatoma)
12/2012 - 08/2005
2Pain (Aches)
09/2011 - 03/2006
1Death (Near-Death Experience)
09/2023
1Brain Neoplasms (Brain Tumor)
05/2023
1Head and Neck Neoplasms (Head and Neck Cancer)
08/2021
1Stomach Neoplasms (Stomach Cancer)
08/2021
1Pulmonary Embolism
08/2021
1Colorectal Neoplasms (Colorectal Cancer)
08/2021
1Liver Diseases (Liver Disease)
05/2021
1Chemical and Drug Induced Liver Injury
05/2021
1Vomiting
03/2021
1Nausea
03/2021
1Idiopathic Pulmonary Fibrosis
01/2020
1Malignant Mesothelioma
11/2019
1Stomatitis
10/2019
1Breast Neoplasms (Breast Cancer)
10/2019
1Paronychia
09/2018
1Inflammation (Inflammations)
11/2017
1Sarcoma (Soft Tissue Sarcoma)
01/2017
1Necrosis
01/2015
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2015
1Ascites
01/2015
1Ulcer
09/2013
1Hepatitis
12/2012
1Febrile Neutropenia
09/2011
1Chromosomal Instability (Chromosome Stability)
07/2010

Drug/Important Bio-Agent (IBA)

10ErbB Receptors (EGF Receptor)IBA
11/2023 - 01/2007
6NivolumabIBA
08/2021 - 11/2017
6Gefitinib (Iressa)FDA Link
11/2017 - 11/2005
5Anaplastic Lymphoma KinaseIBA
11/2017 - 02/2014
4Tyrosine Kinase InhibitorsIBA
03/2021 - 01/2009
3pembrolizumabIBA
11/2022 - 11/2018
3Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
3Monoclonal AntibodiesIBA
08/2021 - 11/2019
3Carboplatin (JM8)FDA LinkGeneric
03/2021 - 06/2008
3CrizotinibIBA
10/2016 - 09/2013
2Bevacizumab (Avastin)FDA Link
08/2021 - 03/2021
2osimertinibIBA
03/2021 - 09/2018
2Cisplatin (Platino)FDA LinkGeneric
01/2018 - 06/2008
2Docetaxel (Taxotere)FDA Link
11/2017 - 09/2011
2Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2017 - 11/2009
2PlatinumIBA
01/2017 - 12/2015
2Messenger RNA (mRNA)IBA
07/2010 - 06/2008
1trastuzumab deruxtecanIBA
11/2023
1NucleotidesIBA
11/2023
1ElementsIBA
09/2023
1lorlatinibIBA
05/2023
1B7-H1 AntigenIBA
11/2022
1Somatostatin Receptors (Somatostatin Receptor)IBA
01/2022
1Pemetrexed (MTA)FDA Link
01/2022
1dabrafenibIBA
01/2022
1trametinibIBA
01/2022
1fibrin fragment D (D-dimer)IBA
08/2021
1FenbendazoleIBA
05/2021
1Olanzapine (Zyprexa)FDA Link
03/2021
1Biomarkers (Surrogate Marker)IBA
01/2020
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
11/2019
1Glycoproteins (Glycoprotein)IBA
11/2019
1EverolimusFDA Link
10/2019
1SteroidsIBA
10/2019
1TOR Serine-Threonine KinasesIBA
10/2019
1AntibodiesIBA
11/2018
1S-1 plus cisplatinIBA
01/2018
1Vinorelbine (Navelbine)FDA LinkGeneric
01/2018
1AfatinibIBA
11/2017
1alectinibIBA
11/2017
1ceritinibIBA
11/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2017
1Octreotide (Sandostatin)FDA LinkGeneric
01/2015
1Tumor Biomarkers (Tumor Markers)IBA
01/2015
1Phosphopyruvate Hydratase (Enolase)IBA
01/2015
1UracilIBA
12/2012
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2012
1Sorafenib (BAY 43-9006)FDA Link
12/2012
1TegafurIBA
12/2012
1FlavonoidsIBA
09/2011
1vadimezanIBA
09/2011
1ran-binding protein 2IBA
07/2010
1Type II DNA Topoisomerases (Topoisomerase II)IBA
07/2010
1Protein Isoforms (Isoforms)IBA
07/2010
1UbiquitinIBA
07/2010
1Ligases (Synthetase)IBA
07/2010

Therapy/Procedure

16Drug Therapy (Chemotherapy)
09/2023 - 11/2005
9Therapeutics
11/2022 - 04/2010
5Radiotherapy
06/2021 - 01/2007
5Chemoradiotherapy
06/2021 - 01/2018
1Terminal Care (Care, Terminal)
09/2023
1Combination Drug Therapy (Combination Chemotherapy)
08/2021
1Self Administration (Administration, Self)
05/2021
1Segmental Mastectomy (Lumpectomy)
04/2021